Table 1.
Treatment | Total exploration time (s) | |
CA1 | BLA | |
Vehicle | 95.5 ± 4.0 | 90.8 ± 4.1 |
Anisomycin | 78.2 ± 7.2 | 95.7 ± 6.2 |
Isoproterenol | 94.5 ± 12.1 | 92.8 ± 7.0 |
Timolol | 101.3 ± 7.4 | 71.1 ± 5.2 |
Timolol+Isoproterenol | 77.5 ± 11.5 | 83.8 ± 8.1 |
SKF38393 | 82.4 ± 7.2 | 91.3 ± 7.0 |
SCH23390 | 94.9 ± 5.7 | 87.0 ± 8.0 |
SCH23390+SKF38393 | 79.45 ± 4.1 | 74.0 ± 5.7 |
Dimaprit | 96.5 ± 9.6 | 103.1 ± 9.8 |
Ranitidine | 89.1 ± 6.0 | 69.9 ± 11.5 |
Ranitidine+Dimaprit | 72.2 ± 8.1 | 76.5 ± 8.8 |
Means ± SEM are shown; one-way ANOVA analysis.